Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	80.11	58.76	71.68	85.96	229.59
Short-Term Investments	92.73	96.61	85.83	63.54	147.32
Trading Asset Securities	-	14.5	28.11	10.65	29.15
Cash & Short-Term Investments	172.84	169.87	185.61	160.16	406.05
Cash Growth	1.75%	-8.48%	15.89%	-60.56%	-1.99%
Accounts Receivable	105.2	88.72	94.89	55.39	62.52
Other Receivables	8.34	9.51	13.68	12.03	19.53
Receivables	113.53	98.23	114	69.96	87.15
Inventory	102.7	91.83	92.49	72.4	56.51
Prepaid Expenses	7.74	4.88	3.34	2.17	2.21
Other Current Assets	-	0.3	0.18	0.29	0.18
Total Current Assets	396.81	365.12	395.62	304.97	552.1
Property, Plant & Equipment	20.02	17.86	22.63	29.94	26.16
Long-Term Investments	103.43	116.36	152.33	174.23	169.79
Goodwill	86.48	79.84	82.27	75.4	77.73
Other Intangible Assets	283.61	289.96	338.78	350.3	156.55
Long-Term Deferred Tax Assets	21.25	19.39	9.31	2.05	2.43
Other Long-Term Assets	52.2	53.3	50.13	51.28	51.18
Total Assets	963.8	945.49	1,055	991.89	1,040
Accounts Payable	78.35	85.37	106.06	65.31	44.51
Short-Term Debt	2.12	0.61	1.61	9.19	10.11
Current Portion of Long-Term Debt	15.37	17.24	16.06	17.48	41.66
Current Portion of Leases	2.64	1.73	2.58	1.61	1.88
Current Income Taxes Payable	0.21	1.18	2.27	7.07	13.56
Other Current Liabilities	12.56	7.9	12.73	4.64	2.34
Total Current Liabilities	111.25	114.03	141.32	105.3	114.06
Long-Term Debt	25.9	44.02	52.4	9.27	-
Long-Term Leases	3.43	5.5	5.05	3.42	2.54
Long-Term Deferred Tax Liabilities	3.84	2.82	4.37	12.37	21.62
Other Long-Term Liabilities	24.27	32.26	25.85	19.52	15.22
Total Liabilities	168.69	198.62	228.98	149.87	153.44
Common Stock	534.27	540.05	599.06	628.85	694.35
Additional Paid-In Capital	25.71	25.99	23.66	21.78	18.73
Retained Earnings	154.79	150.89	161.76	191.65	174.55
Comprehensive Income & Other	80.34	29.95	41.38	-0.26	-1.39
Total Common Equity	795.11	746.87	825.86	842.02	886.24
Shareholders' Equity	795.11	746.87	825.86	842.02	886.24
Total Liabilities & Equity	963.8	945.49	1,055	991.89	1,040
Total Debt	49.46	69.09	77.7	40.96	56.19
Net Cash (Debt)	123.38	108.18	123.08	119.2	365.18
Net Cash Growth	14.04%	-12.10%	3.26%	-67.36%	-23.76%
Net Cash Per Share	1.22	1.01	1.07	0.96	2.77
Filing Date Shares Outstanding	100.05	101.17	110.13	117.03	128.76
Total Common Shares Outstanding	100.05	101.17	112.21	117.78	130.04
Working Capital	285.57	251.09	254.3	199.67	438.04
Book Value Per Share	7.95	7.38	7.36	7.15	6.82
Tangible Book Value	425.02	377.07	404.8	416.32	651.97
Tangible Book Value Per Share	4.25	3.73	3.61	3.53	5.01
Land	0.01	0.93	1.55	1.09	0.89
Buildings	18.5	9.84	14.56	7.69	6.3
Machinery	42.56	21.91	33.13	25.94	18.16

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.